Application 216910
- Type
- ANDA
- Sponsor
- QUAGEN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | GLYCOPYRROLATE | GLYCOPYRROLATE | SOLUTION;ORAL | 1MG/5ML | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A216910-001 | GLYCOPYRROLATE | GLYCOPYRROLATE | 1MG/5ML | SOLUTION / ORAL | AA | 2026-05-18 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A216910-001 | AA |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A216910-001 | GLYCOPYRROLATE | 1MG/5ML | SOLUTION / ORAL | AA | 2026-05-18 | caaa826d4ba7… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A216910-001 | GLYCOPYRROLATE | 1MG/5ML | SOLUTION / ORAL | AA | 2026-05-18 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A216910-001 | AA | 1 | caaa826d4ba7… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A216910-001 | AA | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Glycopyrrolate | GLYCOPYRROLATE | Henry Schein, Inc. | 8b4d1798-c0a7-4661-99cd-1e9a23c16386 | 2025-10-16 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Hikma Pharmaceuticals USA Inc. | 960d2dd0-008d-4ec1-ba2e-9388b28b23e2 | 2025-10-09 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | ProPharma Distribution | 3f2b4281-55f3-43e3-e063-6294a90a56ba | 2025-09-18 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| GLYCOPYRROLATE | GLYCOPYRROLATE | ProPharma Distribution | 3edcc39d-0e29-4585-e063-6394a90ad512 | 2025-09-15 | Warnings, Adverse reactions | GLYCOPYRROLATE GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | ProPharma Distribution | 3edd6a26-dd0f-2411-e063-6394a90affa2 | 2025-09-15 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Alembic Pharmaceuticals Inc. | 327f8a9e-7730-4f38-a7aa-fbddebddf173 | 2025-08-26 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| GLYCOPYRROLATE | GLYCOPYRROLATE | Henry Schein, Inc. | 225d95b4-7f8f-44c2-8fc2-93b75d9cc651 | 2025-08-18 | Warnings, Adverse reactions | GLYCOPYRROLATE GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Precision Dose, Inc. | e58f860b-e955-4d71-a128-93bd3812b08d | 2025-08-08 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| GLYRX-PF | GLYCOPYRROLATE | Exela Pharma Sciences, LLC | 2189f3f5-39dc-4e85-b7c6-9515ded59686 | 2025-07-23 | Warnings, Adverse reactions | GLYCOPYRROLATE |
| GLYCOPYRROLATE | GLYCOPYRROLATE | QUAGEN PHARMACEUTICALS LLC | a456eaea-4cd6-4344-8fc6-6f6a3ce0f2c6 | 2025-06-14 | Warnings, Adverse reactions | GLYCOPYRROLATE GLYCOPYRROLATE |
| GLYCOPYRROLATE | GLYCOPYRROLATE | American Health Packaging | 6404fc8e-d109-4950-9dca-c8a85ad90cf3 | 2025-05-18 | Warnings, Adverse reactions | GLYCOPYRROLATE GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Leading Pharma, LLC | 498bce66-6072-4212-8413-ff9888c58f9c | 2025-04-25 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Chartwell RX, LLC | 89090b34-470c-478c-be49-1d2bc48a28f8 | 2025-04-17 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| GLYCOPYRROLATE | GLYCOPYRROLATE | Aurobindo Pharma Limited | 4b3f8b3e-6fa8-471b-8bee-3dac5e3ea1b8 | 2025-04-17 | Warnings, Adverse reactions | GLYCOPYRROLATE GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | AvPAK | bd497783-e2d1-130c-e053-2995a90a7fb9 | 2025-03-04 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Caplin Steriles Limited | 765490fa-8378-40c8-9fa7-b0bfa2e1a0a9 | 2025-01-25 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| GLYCOPYRROLATE | GLYCOPYRROLATE | HF Acquisition Co LLC, DBA HealthFirst | 9a3a142c-daaf-79af-e053-2995a90a1c51 | 2025-01-08 | Warnings, Adverse reactions | GLYCOPYRROLATE GLYCOPYRROLATE |
| GLYCOPYRROLATE | GLYCOPYRROLATE | HF Acquisition Co LLC, DBA HealthFirst | 9bde90dd-0300-f705-e053-2a95a90a7ea6 | 2025-01-08 | Warnings, Adverse reactions | GLYCOPYRROLATE GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Bryant Ranch Prepack | d93a9b2b-708d-4db5-8aae-45fd3a7ca65c | 2025-01-06 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Cuvposa | GLYCOPYRROLATE | Merz Pharmaceuticals, LLC | d200bd44-9856-4104-a29e-a4cca3db6737 | 2024-12-19 | Warnings, Adverse reactions | GLYCOPYRROLATE |